DUBLIN--(BUSINESS WIRE)--The "Nucleic Acid Isolation and Purification Market by Product (Reagent, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid, miRNA), Application (Precision Medicine), End User (Hospitals, Research Center) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The Global Nucleic Acid Isolation and Purification Market is Expected to Reach USD 4.38 Billion By 2023 from USD 2.77 Billion in 2018, at a CAGR of 9.6%.
Market growth is mainly driven by factors such as increasing public-private funding for life science research, technological advancements, and increasing automation. Emerging economies are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.
On the basis of method, the nucleic acid isolation and purification market is segmented into column-based isolation and purification, reagent-based isolation and purification, magnetic bead-based isolation and purification, and other methods. The magnetic bead-based method is expected to grow at a higher CAGR during the forecast period as this method increases throughput, uses no hazardous chemicals, and can be automated if required.
On the basis of end user, the nucleic acid isolation and purification market is segmented into academic & government research institutes, pharmaceutical & biotechnology companies, contract research organizations, hospitals & diagnostic centers, and other end users. In 2018, academic and government research institutes are expected to account for the largest share of the market due to the increasing research activities and use of nucleic acid tests in molecular diagnostics.
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as favorable regulatory guidelines, lower manufacturing costs, growing presence of market players in emerging economies, and favorable government investments in the life sciences sector.
List of companies profiled in the report
- Agilent Technologies (US)
- Bio-Rad Laboratories (US)
- Danaher Corporation (US)
- Roche (Switzerland)
- GE Healthcare (US)
- Illumina (US)
- Promega Corporation (US)
- Qiagen (Netherlands)
- Merck KGaA (Germany)
- Takara Bio (Japan)
- Thermo Fisher Scientific (US)
- New England Biolabs (US)
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Nucleic Acid Isolation and Purification Market, By Product
7 Nucleic Acid Isolation and Purification Market, By Method
8 Nucleic Acid Isolation and Purification Market, By Type
9 Nucleic Acid Isolation and Purification Market, By Application
10 Nucleic Acid Isolation and Purification Market, By End User
11 Nucleic Acid Isolation and Purification Market, By Region
12 Competitive Landscape
13 Company Profiles
- Agilent Technologies
- Bio-Rad Laboratories
- Danaher Corporation
- F. Hoffman-La Roche
- Ge Healthcare
- Merk KGaA
- New England Biolabs
- Promega Corporation
- Qiagen N.V.
- Takara Bio, Inc.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/kdht3v/nucleic_acid?w=4